Recruiting OBSERVATIONAL NCT05326295

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

Surveillance of Circulating Tumor Cell Phenotype in Early Stage Breast Cancer Patients With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy

Sponsor: Hunan Cancer Hospital

Conditions Breast Neoplasms Chemotherapy Effect Neoplastic Cells, Circulating

Interventions CTC detection

Updated 3 times since 2022 Last updated: Apr 5, 2022 Started: Mar 1, 2019 Primary completion: Mar 1, 2028 Completion: Mar 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05326295, this observational or N/A phase trial focuses on Breast Neoplasms and Chemotherapy Effect and remains actively recruiting participants. Sponsored by Hunan Cancer Hospital, it has been updated 3 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2022 — Jul 2024 [monthly]

Recruiting

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hunan Cancer Hospital

Data source: Hunan Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changsha, China